You cannot apply for this job anymore (deadline was 2 Feb 2020).
Browse the current job offers or choose an item in the top navigation above.
The PhD candidate will perform cutting-edge research in methods applied to tissue engineering and regenerative medicine, and more specifically bioprinting approaches for the creation of a stable and transient chondral microtissues to be incorporated in the aimed implants. PhD candidates will perform their research in an intellectually vibrant and multi-disciplinary environment.
Requirements:
Key expertise:
What we offer:
Fixed-term contract: 1+3 years.
Contract: Four years (first year + three years after receiving a positive evaluation).
The terms of employment of Maastricht University are set out in the Collective Labour Agreement of Dutch Universities (CAO). Furthermore, local UM provisions also apply. For more information look at the website http://www.maastrichtuniversity.nl > Support > UM employees.
The full-time position is offered for four years (first year + three years after receiving a positive evaluation), with a yearly evaluation. The salary will be set in PhD salary scale of the Collective Labor Agreement of the Dutch Universities (€2.325 gross per month in first year to €2.972 last year). On top of this, there is an 8% holiday and an 8.3% year-end allowance. Employees relocating from abroad may be eligible for the Dutch ‘30% ruling’, a tax advantage which results in a significantly higher net salary.
The MERLN Institute for Technology-inspired Regenerative Medicine (https://merlninstitute.com) focuses on developing novel and challenging technologies to advance the field of tissue and organ repair and regeneration through, amongst others, the development of high-throughput material platforms to screen cell-biomaterial interactions. MERLN consists of an interdisciplinary team of researchers including fields as (stem cell) biology, materials engineering, chemistry, micro/nanofabrication, additive manufacturing, etc. The scientists at MERLN have an extensive network of collaborators within research institutions in and outside the Netherlands as well as with a number of biomedical companies, including their own spin-off companies, as entrepreneurship is highly fostered.
At MERLN, the position will be part of the Complex Tissue Regeneration (CTR) department. Research at CTR is driven by technology development for the fabrication of biological constructs. The technological bases at the department for the fabrication of such constructs are:
We like to make it easy for you, sign in for these and other useful features: